NCT05259072View on ClinicalTrials.gov

carDIo-ttranSSfOrm nucLEar Imaging Study

TerminatedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

January 19, 2022

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
AmyloidosisTransthyretin Amyloid Cardiomyopathy
Interventions
DIAGNOSTIC_TEST

99m-technetium pyrophosphate scintigraphy

Imaging test

Trial Locations (1)

97239

Oregon Health & Science University, Portland

Sponsors
All Listed Sponsors
collaborator

Ionis Pharmaceuticals, Inc.

INDUSTRY

lead

Oregon Health and Science University

OTHER